News

ClearSight Offers PanOptix® Trifocal Lens for Cataract Surgery and Custom Lens Replacement, Delivering Clear Vision at All Distances
ClearSight, a leading provider of advanced vision correction solutions, is now offering the PanOptix® Trifocal Intraocular ...
Inexpensive HIV drug can improve vision in patients with common diabetes complication, clinical trial suggests
An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...
Ophthalmology Times8d
Atia Vision receives go-ahead from FDA to begin clinical study of the OmniVu Lens System
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
News-Medical.Net on MSN4d
Affordable HIV drug shows promise in improving vision for diabetic eye disease
An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...
Ophthalmology Times1d
Q&A: Priya S. Vakharia, MD, shares insight into the Phase 2 ARCHER trial for GA
Vakharia insights from the ARCHER trial on geographic atrophy treatment for dry AMD, highlighting promising results and ...
MassDevice11d
Atia Vision can begin intraocular lens trial, FDA says
Atia Vision announced today that it received FDA investigational device exemption (IDE) approval to study its OmniVu lens ...
Nicox Announces up to €3 million in Milestone Payments from Kowa in 2025 as NCX 470 Prepares to Enter Phase 3 Clinical Trials in Japan
Press Release Nicox Announces up to €3 million in Milestone Payments from Kowa in 2025 as NCX 470 Prepares to Enter Phase 3 ...
Vietnam Investment Review on MSN10d
New report charts path for Vietnam’s clinical trial growth
Pharma Group released the ‘Roadmap to the Future of Clinical Trials in Vietnam’ report on May 20 in Ho Chi Minh City.